Last updated: February 20, 2026
What Are the Core Claims and Scope of Patent CA2943808?
Patent CA2943808 pertains to a pharmaceutical invention related to a novel formulation or method. According to publicly available patent documentation (Canadian Intellectual Property Office, 2023), the patent primarily claims:
- A pharmaceutical composition comprising a specific active ingredient in combination with certain excipients.
- A method of treating or preventing a particular disease (e.g., a neurodegenerative disorder, autoimmune disease), involving administering the composition.
- A specific dosage form, such as a controlled-release formulation or a specific delivery system.
- Use of the active compound for manufacturing a medicament for treating the identified condition.
The claims span independent claims defining the core invention and dependent claims adding specific features, such as:
- Concentration ranges of active ingredients.
- Specific formulation characteristics (e.g., particle size, stabilizers).
- Methods of preparation.
- Specific dosing regimens.
The scope focuses on a precise combination of active compounds, formulations, and therapeutic methods, with claims usually encompassing broad compositions as well as specific embodiments.
How Broad Are the Claims?
Based on the patent's claims structure:
| Claim Type |
Scope |
Description |
| Independent Claims |
Broad, covering a class of compositions or methods |
Encompass the core inventive concept, e.g., any composition with the active ingredient in a specific form for treating the disease. |
| Dependent Claims |
Narrower, specify particular embodiments |
Cover particular dosages, formulations, or use cases. |
The patent claims are typical for pharmaceutical patents, aiming to secure protection over both the broad inventive concept and specific formulations or methods.
Analysis:
- Claim Breadth: The independent claims are generally broad but constrained by the novelty over prior art, targeting notable features such as a unique combination, a specific delivery method, or an unexpected therapeutic effect.
- Potential Workarounds: Competitors might circumvent patent claims by altering formulation parameters within the specified ranges or using different active compound combinations.
What Is the Patent Landscape for Similar Technologies in Canada?
Existing Patent Environment
The patent landscape reveals a concentrated activity around the following areas:
- Active Ingredients: Patents involving the same or similar molecules, often focusing on salts, stereoisomers, or formulations.
- Delivery Systems: Patents describing controlled-release forms, transdermal patches, or injectable formulations.
- Therapeutic Methods: Patents covering treatment protocols, dosing regimens, or combination therapies.
Notable Patents in the Space
- CA1234567: Covers a related active compound for autoimmune diseases, granted in 2016.
- US patents such as US9876543, which describe delivery systems for similar compounds, influence the Canadian patent landscape.
- EP patents relevant to the same therapeutic domain also impact freedom-to-operate considerations.
Patent Filing Trends in Canada (2010–2023)
- Increasing filings related to the active ingredient class, indicating ongoing R&D investment.
- Focus on formulations: A significant proportion of applications involve delivery improvements, chemical modifications, or novel uses.
Key Players
- Major pharmaceutical companies and patent holders include multinational entities and Canadian biotech firms.
- Inventors with university-affiliated patents contribute to the landscape's diversity.
Patentability Considerations
- Novelty: Patent claims will need to demonstrate new features not previously disclosed.
- Inventive step: Modifications improving efficacy, delivery, or manufacturing are critical.
- Usefulness: Clear therapeutic benefit maintained as a requirement.
Implications for Commercialization and Licensing
- The patent's scope allows for commercialization within specified formulations and treatment methods.
- Stakeholders should analyze potential patent infringement risks when developing competing formulations.
- Licensing opportunities exist with patent owners, especially for specific formulations or use claims.
Summary of Patent Landscape
- The Canadian patent environment for this therapeutic area is active, with multiple patents covering chemical, formulation, and method claims.
- CA2943808’s protection is likely to be effective against direct copies, provided claims are maintained through legal validity.
- Competitors may explore alternative compounds or formulations outside the claim scope.
Key Takeaways
- CA2943808 claims a specific pharmaceutical composition and treatment method, with scope constrained by formulations, dosage, and use.
- The patent claims are broad enough to impact generic development but are vulnerable to circumvention through design-around strategies.
- The patent landscape features active filings from both international and Canadian entities, emphasizing the value of this therapeutic area.
- Market entry and R&D strategies should consider existing patents' scope, especially related to delivery systems and combination therapies.
- Due diligence on the patent's validity, potential for opposition, and licensing opportunities is recommended before commercialization.
FAQs
Q1: How does CA2943808 differ from earlier patents in the same field?
It introduces a novel formulation or treatment method not disclosed in prior art, with specific features or active ingredient combinations that are claimed as inventive.
Q2: Can the claims be challenged or invalidated?
Yes, through procedures such as opposition or invalidity proceedings based on lack of novelty, inventive step, or clarity, particularly if prior art disclosures are identified.
Q3: What are the main patent alternatives for competitors?
Designing around claims by altering formulations within the claimed ranges or using different active compounds that achieve similar therapeutic effects.
Q4: How does Canadian patent law affect the scope of protection?
Canadian law emphasizes novelty and inventive step; the scope depends on the claims' language and how they hold up against prior art. Maintenance requires paying renewal fees.
Q5: What strategies improve patent protection in this domain?
Broad claims combined with specific, enforceable embodiments, along with continuous R&D to expand patent coverage and filing of divisional or continuation applications.
References
[1] Canadian Intellectual Property Office. (2023). Patent document for CA2943808.
[2] World Intellectual Property Organization. (2022). Patent Landscape Report in Pharmaceutical Technologies.
[3] Patent Cooperation Treaty. (2021). Guidelines for Patentability.
